Skip to main content
. 2022 May 18;12(5):1260. doi: 10.3390/diagnostics12051260

Table 3.

PsA patients with and without crystals across stages of disease activity.

Disease Activity Indices PsA with PsA without p
Crystals (n = 37) Crystals (n = 119)
VAS pain n (%)
mild 2 (5.40%) 90 (75.60%)
moderate 1 (2.70%) 21 (17.60%)
severe 15 (40.50%) 6 (5.00%)
unbearable 19 (51.40%) 2 (1.70%) <0.001
DAPSA n (%)
low disease activity 6 (16.20%) 65 (54.60%)
moderate disease activity 3 (8.10%) 35 (29.40%)
high disease activity 28 (75.70%) 19 (16.00%) <0.001
PASDAI n (%)
low disease activity 12 (32.40%) 77 (64.70%)
moderate disease activity 12 (32.40%) 39 (32.80%)
high disease activity 13 (35.10%) 3 (2.50%) <0.001
mCPDAI n (%)
low disease activity 8 (21.60%) 90 (75.60%)
moderate disease activity 4 (10.80%) 14 (11.80%)
high disease activity 25 (67.60%) 15 (12.60%) <0.001
HAQ-DI n (%)
mild disability 10 (27.00%) 68 (57.10%)
moderate disability 5 (13.50%) 40 (33.60%)
severe disability 22 (59.50%) 11 (9.20%) <0.001